Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
CGTX
#3362
Cognition Therapeutics, Inc. Common Stock
1.0
9
-5.22%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-5.22%
Monthly Change
-18.66%
6 month change
-58.87%
Cambio anual
+142.22%
Cierres anteriores
1.1
5
Open
1.0
9
Bid
Ask
Low
1.0
9
High
1.0
9
Volumen
16
Markets
Acciones
Atención Sanitaria
CGTX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Noticias
Cognition Therapeutics bespricht mit FDA nächste Studienphase für Demenz-Medikament
Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug
Cognition Therapeutics meldet positive Phase-2-Studienergebnisse für DLB-Medikament
Cognition’s DLB drug shows positive results in phase 2 trial
Cognition Therapeutics schließt Patientenrekrutierung für DLB-Studienprogramm ab
Cognition Therapeutics completes enrollment in expanded access program
Cognition Therapeutics skizziert Pläne für Phase-3-Studie mit Alzheimer-Wirkstoff
Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug
Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)
Alzheimer-Studie: Cognition Therapeutics erreicht Rekrutierungsziel
Cognition Therapeutics completes enrollment in Alzheimer’s drug trial
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?